Applied dna and evvivax announce publication of positive preclinical data for lineardna™ platform approach to cancer immunotherapy

Stony brook, n.y. & rome--(business wire)---- $apdn #cancervaccine--first published study demonstrates lineardna pan-cancer and colon cancer neoantigen.
APDN Ratings Summary
APDN Quant Ranking